Clinical Discussion Series
|First-line Treatment of HL: Differential Treatment Strategies in Newly Diagnosed Patients with Early- versus Advanced-Stage Disease|
Andrew M. Evens, DO, MSc, FACP
|Release Date: April 27, 2016|
Expiration Date: April 27, 2017
Dr. Andrew Evens will address the critical differences in therapeutic strategies for patients who are diagnosed with early stage HL versus those who are diagnosed at an advanced stage. Through a practical review of the newest regimens and strategies, Dr. Evens will discuss the latest evidence supporting the differential use of each as first-line therapy for the newly diagnosed HL patient.
To download the accompanying e-Transcript for reference purposes only click here.Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Takeda Oncology
|View Only, CE ExpiredView Only, No Credit|